Title of article
Decitabine Induced Delayed Cardiomyopathy in Hematologic Malignancy
Author/Authors
Agasthi, Pradyumna Department of Cardiovascular Diseases - Mayo Clinic, Arizona, USA , Narayanasamy, Hemalatha Department of Cardiovascular Diseases - Mayo Clinic, Arizona, USA , Sorajja, Dan Department of Cardiovascular Diseases - Mayo Clinic, Arizona, USA , Slack, James Department of Cardio-Oncology - Mayo Clinic, Arizona, USA , Mookadam, Farouk Department of Cardio-Oncology - Mayo Clinic, Arizona, USA
Pages
5
From page
1
To page
5
Abstract
Decitabine is a pyrimidine analogue of nucleoside cytidine, used for the treatment of myelodysplastic syndromes, chronic
myelogenous leukemia, and acute myelogenous leukemia. We present a case of cardiomyopathy associated with decitabine
used for secondary acute myelogenous leukemia. The patient presented with new heart failure symptoms and an ejection
fraction decline.
Keywords
Decitabine Induced Delayed , Cardiomyopathy , Hematologic Malignancy
Journal title
Case Reports in Cardiology
Serial Year
2018
Full Text URL
Record number
2611118
Link To Document